+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Ophthalmology Drugs and Devices Market 2019-2027

  • ID: 4827811
  • Report
  • August 2019
  • Region: Europe
  • 102 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 4

FEATURED COMPANIES

  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • MORE
Market Outlook

The report has determined the European ophthalmology drugs and devices market to flourish at a compound annual growth rate of 5.99% throughout the forecast duration of 2019-2027. The United Kingdom, France, Germany, Spain, Italy, Russia and countries in rest of Europe together comprise the market for ophthalmology drugs and devices in the European region. The Germany ophthalmological drugs and devices market is mainly driven by the highest healthcare expenditure by the country in the entire European region, along with the initiatives taken by the private organizations considering the development & growth of ophthalmology in the country. According to company sources, Optegra Organizations, an international provider of eye surgery has acquired Memira Organization’s operations, aiming to provide ophthalmological services across the urban and semi-urban provinces of the country, that include the ophthalmology clinics in Stuttgart and Munich. The Optegra Organization provides general ophthalmology services in many ranges of eye applications which include retinal, glaucoma, orbitofacial and corneal. According to the Organization for Economic Cooperation and Development, the healthcare expenditure of Germany accounted for $5,119 per capita in 2014, which reached at $5,267 per capita in 2015, that may support various researches in ophthalmology, which positively influences the growth of the ophthalmology drugs and devices market in Germany.

Competitive Outlook
The biggest brands in the market are Novartis International AG, Pfizer, Roche Holding AG, Santen Pharmaceutical Co., Ltd., Sun Pharmaceuticals Industries, Ltd., Valeant Pharmaceuticals International, Inc. and Ziemer Group Holding AG.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • MORE
1. Europe Ophthalmology Drugs and Devices Market - Summary

2. Industry Outlook
2.1. Porter's Five Force Analysis
2.1.1. Bargaining Power of Buyers
2.1.2. Bargaining Power of Supplier
2.1.3. Threats of New Entrants
2.1.4. Threats of Substitutes
2.1.5. Competitive Rivalry
2.2. Strategic Outlook
2.3. Key Insight
2.4. Value Chain Outlook
2.5. Key Buying Standards
2.6. Supply Chain Outlook
2.7. Regulatory Framework
2.8. Market Drivers
2.8.1. Increasing Ophthalmic Disorders Due to High Blood Sugar
2.8.2. Upsurge in Healthcare Spending
2.8.3. Technological Advancement
2.9. Market Restraints
2.9.1. Expirations of Brand Patents Have Affected the Pharmaceutical Industry
2.9.2. Low Cognizance Related to Ophthalmic Drugs
2.9.3. Drug Approvals Delay and Number of Drugs in the Pipeline
2.10. Market Opportunities
2.10.1. Demand for Phacoemulsification Devices and Intraocular Lenses Is Increasing
2.11. Market Challenges
2.11.1. Difficulties Associated With the Conduct of Ocular Diseases

3. Ophthalmology Drugs and Devices Market Outlook - by Drugs and Devices
3.1. Devices
3.1.1. Diagnostic & Monitoring Equipment
3.1.1.1. Optical Coherence Tomography
3.1.1.2. Ophthalmic Ultrasound Imaging Systems
3.1.1.3. Fundus Camera Market
3.1.1.4. Ophthalmoscopes
3.1.1.5. Retinoscope
3.1.1.6. Pachymeter
3.1.1.7. Wavefront Aberrometers
3.1.1.8. Perimeters/Visual Field Analyzer
3.1.1.9. Autorefractors/Phoropter
3.1.1.10. Specular Microscope
3.1.1.11. Corneal Topographers
3.1.1.12. Other Diagnostic & Monitoring Equipment Market
3.1.2. Surgery Devices
3.1.2.1. Cataract Surgery Devices
3.1.2.2. Glaucoma Surgery Devices
3.1.2.3. Refractive Surgery Devices
3.1.2.4. Vitreoretinal Surgery Devices
3.1.3. Vision Care
3.2. Drugs
3.2.1. Glaucoma Drug
3.2.2. Retinal Disorder Drug
3.2.3. Dry Eye Drug
3.2.4. Allergic Conjunctivitis, Inflammation and Conjunctivitis Drug
3.2.5. Drugs by Use of Preservation
3.2.5.1. Preserved Drugs
3.2.5.2. Preservative-Free Drugs

4. Ophthalmology Drugs and Devices Market - Regional Outlook
4.1. The United Kingdom
4.2. France
4.3. Germany
4.4. Spain
4.5. Italy
4.6. Russia
4.7. Rest of Europe

5. Competitive Landscape
5.1. Allergan, Inc.
5.2. Bayer
5.3. Carl Zeiss AG
5.4. Essilor International S.A.
5.5. Glaxosmithkline
5.6. Johnson & Johnson, Inc.
5.7. Novartis International AG
5.8. Pfizer
5.9. Roche Holding AG
5.10. Santen Pharmaceutical Co., Ltd.
5.11. Sun Pharmaceuticals Industries, Ltd.
5.12. Valeant Pharmaceuticals International, Inc.
5.13. Ziemer Group Holding AG

6. Methodology and Scope
6.1. Research Scope
6.2. Sources of Data
6.3. Research Methodology

List of Tables
Table 1 Europe Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Table 2 Common Causes of Loss of Vision in the Elderly
Table 3 Selected List of Glaucoma Drugs in Late-Stage Clinical Trials
Table 4 Europe Ophthalmology Drugs and Devices Market by Drugs and Devices 2019-2027 ($ Million)
Table 5 Europe Devices Market in Diagnostic & Monitoring Equipment by Types 2019-2027 ($ Million)
Table 6 Europe Devices Market in Surgery Device by Types 2019-2027 ($ Million)
Table 7 Europe Drugs and Devices Market in Drugs by Types 2019-2027 ($ Million)
Table 8 Europe Ophthalmology Drugs and Devices Market by Countries 2019-2027 ($ Million)

List of Figures
Figure 1 Europe Ophthalmology Drugs and Devices Market 2019-2027
Figure 2 Europe Drugs and Devices Market in Devices 2019-2027 ($ Million)
Figure 3 Europe Devices Market Diagnostic & Monitoring Equipment in 2019-2027 ($ Million)
Figure 4 Europe Diagnostic & Monitoring Equipment Market in Optical Coherence Tomography 2019-2027 ($ Million)
Figure 5 Europe Diagnostic & Monitoring Equipment Market in Ophthalmic Ultrasound Imaging Systems 2019-2027 ($ Million)
Figure 6 Europe Diagnostic & Monitoring Equipment Market in Fundus Camera Market 2019-2027 ($ Million)
Figure 7 Europe Diagnostic & Monitoring Equipment Market in Ophthalmoscopes 2019-2027 ($ Million)
Figure 8 Europe Diagnostic & Monitoring Equipment Market in Retinoscope 2019-2027 ($ Million)
Figure 9 Europe Diagnostic & Monitoring Equipment Market in Pachymeter 2019-2027 ($ Million)
Figure 10 Europe Diagnostic & Monitoring Equipment Market in Wavefront Aberrometers 2019-2027 ($ Million)
Figure 11 Europe Diagnostic & Monitoring Equipment Market in Perimeters/Visual Field Analyzer 2019-2027 ($ Million)
Figure 12 Europe Diagnostic & Monitoring Equipment Market in Autorefractors/Phoropter 2019-2027 ($ Million)
Figure 13 Europe Diagnostic & Monitoring Equipment Market in Specular Microscope 2019-2027 ($ Million)
Figure 14 Europe Diagnostic & Monitoring Equipment Market in Corneal Topographers 2019-2027 ($ Million)
Figure 15 Europe Diagnostic & Monitoring Equipment Market in Other Diagnostic & Monitoring Equipment Market 2019-2027 ($ Million)
Figure 16 Europe Devices Market in Surgery Device 2019-2027 ($ Million)
Figure 17 Europe Surgery Devices Market in Cataract Surgery Devices 2019-2027 ($ Million)
Figure 18 Europe Surgery Devices Market in Glaucoma Surgery Devices 2019-2027 ($ Million)
Figure 19 Europe Surgery Devices Market in Refractive Surgery Devices 2019-2027 ($ Million)
Figure 20 Europe Surgery Devices Market in Vitreoretinal Surgery Devices 2019-2027 ($ Million)
Figure 21 Europe Devices Market in Vision Care Market 2019-2027 ($ Million)
Figure 22 Europe Drugs and Devices Market in Drugs 2019-2027 ($ Million)
Figure 23 Europe Drugs Market in Glaucoma Drug 2019-2027 ($ Million)
Figure 24 Europe Drugs Market in Retinal Disorder Drug 2019-2027 ($ Million)
Figure 25 Europe Drugs Market in Dry Eye Drug 2019-2027 ($ Million)
Figure 26 Europe Drugs Market in Allergic Conjunctivitis, Inflammation and Conjunctivitis Drug 2019-2027 ($ Million)
Figure 27 Europe Drugs by Use of Preservation in Preserved Drugs 2019-2027 ($ Million)
Figure 28 Europe Drugs by Use of Preservation in Preservative-Free Drugs 2019-2027 ($ Million)
Figure 29 Europe Preservative-Free Drugs Market in Single-Dose 2019-2027 ($ Million)
Figure 30 Europe Preservative-Free Drugs Market in Multi-Dose 2019-2027 ($ Million)
Figure 31 The United Kingdom Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 32 France Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 33 Germany Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 34 Spain Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 35 Italy Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 36 Russia Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 37 Rest of Europe Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Essilor International S.A.
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • Pfizer
  • Roche Holding AG
  • Santen Pharmaceutical Co., Ltd.
  • Sun Pharmaceuticals Industries, Ltd.
  • Valeant Pharmaceuticals International, Inc.
  • Ziemer Group Holding AG
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll